These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2657912)
21. Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain. Berg J; Lötscher E; Steimer KS; Capon DJ; Baenziger J; Jäck HM; Wabl M Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4723-7. PubMed ID: 1905015 [TBL] [Abstract][Full Text] [Related]
22. [Repertoire of epitopes of human immunodeficiency virus proteins and the search for vaccines and diagnostic kits]. Kharchenko EP; Klimenko AP Dokl Akad Nauk SSSR; 1992; 322(1):189-92. PubMed ID: 1380907 [No Abstract] [Full Text] [Related]
23. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins. Mills KH; Nixon DF; McMichael AJ AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396 [No Abstract] [Full Text] [Related]
24. Multiple cytotoxic effector cells are induced by infection with the human immunodeficiency virus. Rivière Y; Tanneau-Salvadori F; Regnault A; Lopez O; Sansonetti P; Guy B; Kieny MP; Fournel JJ; Montagnier L Res Immunol; 1989 Jan; 140(1):110-5; discussion 121. PubMed ID: 2657908 [No Abstract] [Full Text] [Related]
26. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Sethi KK; Näher H; Stroehmann I Nature; 1988 Sep; 335(6186):178-81. PubMed ID: 2842692 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T-cell recognition of HIV proteins and peptides. Nixon DF; McMichael AJ AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319 [No Abstract] [Full Text] [Related]
28. Cytotoxic potential of CD8+ T-cells in lymphoid follicles during HIV-1 infection. Laman JD; van den Eertwegh AJ AIDS; 1992 Mar; 6(3):333-5. PubMed ID: 1567581 [No Abstract] [Full Text] [Related]
29. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection. McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716 [TBL] [Abstract][Full Text] [Related]
30. Why high levels of virus-specific CTL persist in HIV1-infected individuals. Koup RA; Sullivan JL Res Immunol; 1989 Jan; 140(1):92-5; discussion 118-9. PubMed ID: 2543042 [No Abstract] [Full Text] [Related]
31. HIV and AIDS. Laman JD Science; 1993 Jun; 260(5115):1707-8. PubMed ID: 8511573 [No Abstract] [Full Text] [Related]
32. Immune surveillance and AIDS progression. Zinkernagel R; Klenerman P Curr Biol; 1997 Jul; 7(7):R403-5. PubMed ID: 9210384 [No Abstract] [Full Text] [Related]
33. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS. Wasik TJ; Wierzbicki A; Whiteman VE; Trinchieri G; Lischner HW; Kozbor D Eur J Immunol; 2000 Jan; 30(1):117-27. PubMed ID: 10602033 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment. Dadaglio G; Michel F; Langlade-Demoyen P; Sansonetti P; Chevrier D; Vuillier F; Plata F; Hoffenbach A Clin Exp Immunol; 1992 Jan; 87(1):7-14. PubMed ID: 1733639 [TBL] [Abstract][Full Text] [Related]
35. T lymphocyte responses in HIV-1 infection: implications for vaccine development. Brander C; Walker BD Curr Opin Immunol; 1999 Aug; 11(4):451-9. PubMed ID: 10448136 [TBL] [Abstract][Full Text] [Related]
36. Cytotoxic T cells--protection from disease progression--protection from infection. Gotch F; Gallimore A; McMichael A Immunol Lett; 1996 Jun; 51(1-2):125-8. PubMed ID: 8811356 [TBL] [Abstract][Full Text] [Related]